Extended Interval Aminoglycoside Dosing/Monitoring Guidelines

1. Ali MZ, Goetz MB.  A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.  Clin Infect Dis 1997;24:796-809.
2. Ariano RE.  A critical evaluation of “once daily” aminoglycoside therapy.  Health Sciences Centre Drug Info Bulletin 1993;15(6).
3. Bailey TC, Little JR, Littenberg B, et al.  A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.  Clin Infect Dis 1997;24:786-95.
4. Bates RD, Nahata MC.  Once-daily administration of aminoglycosides.  Ann Pharmacother 1994;28:757-66.
5. Bertino JS, Rotschafer JC.  Editorial response: single daily dosing of aminoglycosides-a concept whose time has not yet come.  Clin Infect Dis 1997;24:820-23.
6. Blaser J, Konig C, Simmen HP, et al.  Monitoring serum concentrations for once-daily netilmicin dosing regimens.  J Antimicrob Chemother 1994;33:341-8.
7. Conly JM, Gold W, Shafran SD.  Once-daily aminoglycoside dosing: a new look at an old drug.  Can J Infect Dis 1994;5:205-6.
8. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, et al.  Extended-interval aminoglycoside administration for children:  a meta-analysis.  Pediatrics 2004;114:e111-8.
9. Craig WA.  Once-daily dosing of aminoglycosides.  Can J Infect Dis 1994;5:28C-33C.
10. Gilbert DN.  Editorial response: meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides.  Clin Infect Dis 1997;24:816-19.
11. Gilbert DN.  Minireview: once-daily aminoglycoside therapy.  Antimicrob Agents Chemother 1991;35:399-405.
12. Hatala R, Dinh T, Cook DJ.  Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.  Ann Intern Med 1996;124:717-25.
13. Hatala R, Dinh TT, Cook DJ.  Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review.  Clin Infect Dis 1997;24:810-15.
14. Hemsworth S, Nunn AJ, Selwood K, et al.  Once-daily netilmicin for neutropenic pyrexia in paediatric oncology.  Acta Paediatr 2005;94:268-74.
15. Hitt CM, Klepser ME, Nightingale CH, et al.  Pharmacoeconomic impact of once-daily aminoglycoside administration.  Pharmacotherapy 1997;17:810-14.
16. Kirkpatrick CMJ, Duffull SB, Begg EJ.  Once-daily aminoglycoside therapy: potential ototoxicity.  Antimicrob Agents Chemother 1997;41:879-80.
17. Knoderer CA, Everett JA, Buss WF.  Clinical issues surrounding once-daily aminoglycoside dosing in children.  Pharmacother 2003;23:44-56.
18. Levison ME.  New dosing regimens for aminoglycoside antibiotics.  Ann Intern Med 1992;117:693-4.
19. Marra F, Partovi N, Jewesson P.  Aminoglycoside administration as a single daily dose: an improvement to current practice or a repeat of previous errors?  Drugs 1996;52:344-70.
20. Nicolau DP, Freeman CD, Belliveau PP, et al.  Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.  Antimicrob Agents Chemother 1995;39:650-5.
21. Prins JM, Buller HR, Kuijper EJ, et al.  Once versus thrice daily gentamicin in patients with serious infections.  Lancet 1993;341:335-9.
22. Smyth A, Tan KHV, Hyman-Taylor P, et al.  Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study:  a randomised controlled trial.  Lancet 2005;365:573-8.VandenBussche HL, Klepser MR.  Editorial.  Lancet 2005;365:547-8.
23. Sung L, Dupuis LL, Bliss B, et al.  Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.  J Natl Cancer Inst 2003;95:1869-77.
24. Tomlinson RJ, Ronghe M, Goodbourne C, et al.  Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.  Arch Dis Child 1999;80:125-31.
25. Zaske DE.  Aminoglycosides.  In: Evans WE, Schentag JJ, Jusko WJ, eds.  Applied pharmacokinetics: principles of therapeutic drug monitoring.  Vancouver, WA: Therapeutics; 1992;14:1-47.